Biotech Week articles from April 2002

Biotech Week archives from April 2002

Tenofovir less toxic than similar drugs.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - The antiretroviral drug tenofovir is less toxic than other agents with similar methods of action, researchers in California report. "Drug-associated...

Canadian group announces small animal model for hepatitis C.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A group in Canada says they have developed a way to study hepatitis C virus (HCV) in a more readily available and less costly animal model. HCV does not...

ABT-773 effective against macrolide-resistant streptococcus.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States say that a novel antimicrobial drug provides superior activity against drug-resistant streptococcus and staphylococcus...

New collaboration increases potential in protein purification.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Under a new agreement, Amersham Biosciences and Affibody will work to develop affinity-based products for use in the production processes for protein-based pharmaceuticals. The development of these...

Dupuytren's clinical trial results announced.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- BioSpecifics Technologies Corp. (BSTC) announced that results of a phase 2 placebo-controlled, double-blind, dose-response trial using its product candidate Cordase were presented at the 48th Annual...

Markers of Hantavirus infection identified.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have identified several factors which are useful for distinguishing between true Hantavirus infection and conditions with...

Joint research program to develop library of polymers.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Nobex Corp. and Albany Molecular Research, Inc., (AMRI) have entered into a collaborative research program to develop a comprehensive library of Nobex proprietary polymers for use in pharmaceuticals as...

DNA vaccine can provide mucosal protection.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - DNA vaccines may represent a safer and equally effective alternative to live, attenuated HIV vaccines, researchers in the United States argue. "An...

Gil Medina joins board of trustees.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- The Biotechnology Council of New Jersey (BCNJ) has announced that Gualberto "Gil" Medina, the former Secretary of the Commerce and Economic Growth Commission, has joined the board of trustees. The...

Company announces financial results for 4Q, year-end.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- 3-Dimensional Pharmaceuticals, Inc., (DDDP) announced results for the fourth quarter and fiscal year ended December 31, 2001. Revenues for the quarter increased to $10.2 million, compared with $3.8...

Rudolph named VP, general counsel; Gill named COO.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- 3-Dimensional Pharmaceuticals, Inc., (3DP) (DDDP) announced the appointment of Melinda Rudolph to the position of vice president and general counsel. Rudolph was formerly a partner with Harkins...

Company acquires targeted therapeutic division of Biotech Australia.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Access Pharmaceuticals, Inc., (AKC) announced the acquisition of the targeted therapeutic technology of Biotech Australia. Under the terms of the agreement, Access will acquire the patents to three...

Company posts strong 2001 fourth quarter, full-year financial results.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- American Pharmaceutical Partners, Inc., (APPX) reported financial results for the fourth quarter and year ended December 31, 2001. In December 2001, American Pharmaceutical Partners (APP) completed its...

Array BioPharma announces exercise of over-allotment option.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Array BioPharma, Inc., (ARRY) announced that the underwriters of the company's recent public offering exercised in full their over-allotment option on February 25, 2002, and purchased an additional...

Atofina Chemicals announces biotech strategic partnership.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Atofina Chemicals announced a strategic partnership with Buffers and Biochemicals Corp. (BBC) of Loveland, Ohio. Under the terms of the agreement, Atofina Chemicals will provide global marketing for...

FDA gives approval to generic Adderall tablets.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc., (BRL) announced that it has received approval from the U.S. Food and Drug Administration for dextroamphetamine saccharate, amphetamine aspartate, dextroamphetimine sulfate,...

Fusion Medical Technologies to be acquired.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Baxter International, Inc., (BAX) and Fusion Medical Technologies, Inc., (FSON) jointly announced that they have entered into an agreement under which Baxter will acquire Fusion, a company which...

Harvard Medical School dean appointed to board of directors.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Baxter International, Inc., (BAX) announced that Joseph Martin, MD, PhD, has been elected to serve as a member of its board of directors. Martin is the dean of the Harvard University Faculty of...

Amgen won't pursue development, commercialization under licensing agreements.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Bioject Medical Technologies, Inc., (BJCT), a leading developer of needle-free drug delivery systems, announced that Amgen, Inc., has given notice to the company of its election not to pursue further...

Bradley Pharmaceuticals announces record-setting 2001 financial results.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Bradley Pharmaceuticals, Inc., (BPRX) announced net sales for the year ended December 31, 2001, reached $25.7 million versus in the year 2000 net sales of $18.6 million, an increase of $7.1 million, or...

Study stirs controversy over human genome project.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- A private company that mapped the human genome would not have been able to complete its work without data provided by competing public laboratories, which was not apparent in scientific publication of...

Maxygen announces launch of wholly owned chemicals subsidiary.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Maxygen, Inc., (MAXY) announced the establishment of its wholly owned chemicals subsidiary, Codexis, Inc. Its proprietary technologies allow for the rapid discovery and development of catalysts and...

McEvoy promoted to vice president of research.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Corgentech, Inc., a privately held biotechnology company, announced that Leslie McEvoy, PhD has been promoted to vice president of research. McEvoy has served as senior director of research since...

Company reports fourth quarter, year-end results.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Corvas International, Inc., (CVAS) reported financial results for the fourth quarter and the year ended December 31, 2001, which were in line with management's expectations. Fourth quarter...

Company names John V. Hargiss president and COO.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Cryo-Cell International, Inc., (CCEL) has named John V. Hargiss to the position of president and chief operating officer. Hargiss was selected from an extensive search of hundreds of candidates,...

Digene files Hart-Scott-Rodino notification.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Digene Corp. (DIGE) announced that it has filed its notification and report form pursuant to the Hart-Scott-Rodino Antitrust Improvements Act of 1976 in connection with the execution, on February 19,...

Company announces fourth quarter, full-year 2001 results.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Dynacare, Inc., (DNCR) a leading provider of clinical laboratory services in North America, announced financial results for the fourth quarter and 12 months ended December 31, 2001. Revenues for...

Endostatin receives FDA orphan drug status.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- EntreMed, Inc., (ENMD), a biopharmaceutical leader in angiogenic research and product development, announced that its drug candidate Endostatin received orphan drug status from the U.S. Food and Drug...

Company reports 49% growth in sales.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Gum Tech International, Inc., (GUMM), developer and distributor of Zicam Cold Remedy and Zicam Allergy Relief, announced that annual product sales increased 49% for the fiscal year ending December 31,...

ZymoGenetics files patent infringement suit.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- ZymoGenetics, Inc. (ZGEN) has filed a patent infringement lawsuit today against Immunex Corp. The suit, filed in the United States District Court for the Western District of Washington in Seattle,...

Anapharm extends usage of InnaPhase technology with EP series.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- InnaPhase Corp., a leading provider of enterprise technology solutions for life sciences, announced that Anapharm has signed a license agreement for InnaPhase's Enterprise Pharmacology Series product....

Rael announces a new candidate for human cloning.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Rael, leader of the International Raelian Movement, recently announced during a press conference in London that Clonaid, the company claiming to be in the process of giving birth to the first human...

Reed elected to board of directors.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Isis Pharmaceuticals, Inc., (ISIS) announced that John C. Reed, MD, PhD, has been elected to the company's board of directors. Reed is president and chief executive officer of the Burnham Institute in...

Advance drug delivery to top $7B in revenues.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- The market for drugs employing advanced drug delivery technologies is expanding rapidly and will surpass $7 billion by 2005, according to a new study released from Kalorama Information. The segment has...

Management reviews 2001 operating results, provides guidance for 2002.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- LifeCell Corp. (LIFC) increased product revenues in 2001 by 25% to $26.6 million, while at the same time achieving improved efficiency in its tissue processing operations and reducing general and...

Registration statement filed for IPO.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- LipoScience, Inc., has filed a registration statement with the Securities and Exchange Commission for an initial public offering of shares of its common stock. All of the shares are being offered by the...

R. Michael Blaese, MD, joins scientific advisory board.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- MaxCyte has named R. Michael Blaese, MD, as the newest member of its scientific advisory board. Blaese has over 35 years of experience in biomedical research in the areas of genetics,...

New chair and member join board of directors.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Medwave, Inc., (MDWV) has announced that William Corneliuson will assume the responsibilities of chairman of the board of directors and that John Miclot has joined board of directors, effective...

ImClone Systems and FDA discuss resubmission of Erbitux.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Merck KGaA has confirmed that it was represented at the March meeting between its strategic partner ImClone Systems Inc., Bristol-Myers Squibb Co., and the U.S. Food and Drug Administration (FDA). ...

Al Schallop promoted to president and COO, MesoSystems.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- MesoSystems Technology, Inc., a biodefense company that makes products for the collection and detection of biological hazards such as anthrax, promoted Al Schallop to president and chief operating...

FDA approves ANDA for Metformin.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- United Research Laboratories/Mutual Pharmaceutical Co. announced that the Food and Drug Administration (FDA) has approved Mutual Pharmaceutical's abbreviated new drug application (ANDA) for Metformin...

Michael J. Gerber named senior VP of clinical development and regulatory affairs.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Myogen, Inc., a Colorado-based biopharmaceutical company, announced the appointment of Michael J. Gerber, MD, as senior vice president of clinical development and regulatory affairs. Dr. Gerber has...

Company breaks even in fourth quarter.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Neose Technologies, Inc., (NTEC) announced that for the quarter ended December 31, 2001, the company reported net income of $4000, or breakeven on a per share basis, compared with a net loss of $2.1...

Company releases financial results for year-end 2001.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Novuspharma SpA (NOV) has announced financial results for the year ended December 31, 2001, and an update on clinical development. Among the highlights: * Continued progress with lead product, BBR...

Company adds VP and plant manager.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Nutraceutical Clinical Laboratories International, Inc., (NCCL) has named Burt Sookram as vice president, research and development/quality assurance and George Merrell as plant manager. Sookram,...

OmniViz to provide integrated analysis of Affymetrix array data.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- OmniViz, Inc., announced that it is collaborating with Affymetrix, Inc., (AFFX) to include seamless access within the OmniViz software system to Affymetrix Analysis Data Model (AADM)-compliant...

Bettina Steffen named new vice president.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Bettina J. Steffen, MD, has joined ProSanos Corp. as vice president for market development. In this newly created position, she will lead the company's account management and market development efforts....

Collaboration with Japanese firm announced.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Ribozyme Pharmaceuticals, Inc., (RZYM) has entered into an agreement with Fujirebio, the largest domestic diagnostic company in Japan, to develop and commercialize ribozyme-based clinical diagnostic...

Om P. Goel named VP, process chemistry.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Ricerca, LLC, a drug development company, announced that Om P. Goel, PhD, has joined the company as vice president of process chemistry. He will be in charge of managing Ricerca's process chemistry...

Sequitur launches of mRNA catcher.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Sequitur, Inc., has announced commencement of sales of the RNA Catcher - a high throughput mRNA isolation system. The mRNA Catcher technology has revolutionized high throughput gene expression...

MTF enters agreement on advanced bone graft technology.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- The Musculoskeletal Transplant Foundation (MTF) and Spineology have entered into a development, distribution, and marketing agreement. Under the terms of the agreement, the companies will codevelop...

Robert L. Zerbe, MD, joins the board.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Synaptic Pharmaceutical Corp. (SNAP) has announced that Robert L. Zerbe, MD, has joined its board of directors. Zerbe has more than 20 years of broad drug development experience that has included...

Polypore, Inc., acquires Membrana.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- The Acordis Group has sold its Wuppertal-based business unit, Membrana GmbH, to Polypore, Inc. Financial details were not disclosed. Membrana manufactures high performance membranes for medical...

Thermogenesis inks European distribution agreement for fibrin sealant system.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Thermogenesis Corp. (KOOL) today announced that it has signed a distribution agreement with Dideco, S.p.A., in Mirandola, Italy to begin immediate commercialization of its CryoSeal Fibrin Sealant (FS)...

Company spins out from GSK and FLIR, completes $6.5MM private equity financing, and appoints board of directors.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Thermogenic Imaging, manufacturer of bioanalytical instruments for drug research and development, announced that it has completed a concurrent spin-out and $6.5MM venture financing. The company has...

Ivan D. Trifunovich, new senior VP, will lead company's new genomics business unit.
April 3, 2002... 2002 APR 3 - (NewsRx.com & NewsRx.net) -- Third Wave Technologies, Inc., (TWTI) announced the appointment of Ivan D. Trifunovich as senior vice president and general manager of its genomics business unit. Third Wave recently created two...

Extended cell phone signal exposure can damage blood cell chromosomes.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Extended exposure to the type of signals given off by cell phones can cause genetic damage to blood cells, researchers in the United States warn. Raymond...

Scientists develop new drug to combat tamoxifen-resistant tumors.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- An antiestrogen compound discovered only 4 years ago, has been found to inhibit the growth of breast cancer cells using a unique mechanism which enables it to work against tumors that are resistant to...

Access reports positive results of preclinical studies.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- Access Pharmaceuticals, Inc., announced positive results of two preclinical studies of the company's mucositis technology for the prevention and treatment of oral mucositis and its plan to advance this...

Compounds demonstrate benefit in filtration, angiogenesis in peritoneal dialysis study.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- Findings from a preclinical study of two of Alteon's investigational drugs support the company's ongoing development of a treatment for the critically ill population of end-stage renal disease patients...

Ketek active in treatment of acute maxillary sinusitis caused by drug resistant bacteria.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- Clinical trial results presented at the 58th Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI) found that Ketek (telithromycin) is active in patients with acute maxillary...

Company proceeds with analysis of pivotal phase III Vitrase data.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- ISTA Pharmaceuticals, Inc., (ISTA) announced it will begin the process of unmasking data and initiating the analysis of its phase III studies of Vitrase for the treatment of severe vitreous hemorrhage....

Orthosonix launches Energex therapy for dental offices.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- Orthosonix, Inc., has introduced Energex, a pulsed radio frequency tissue stimulation system that reduces the pain associated with temporomandibular joint arthalgia (TMJA). Energex is a highly...

U.K. grants patent for design and synthesis of zinc finger DNA-binding proteins.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- Sangamo BioSciences, Inc., (SGMO) has announced that the company has been granted a patent in the United Kingdom entitled "Selection of Sites for Targeting by Zinc Finger Proteins and Methods of...

NIH funds new research on A2a agonists as neuroprotectants.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- Adenosine Therapeutics, LLC, announced the award of a Fast Track SBIR grant from the U.S. National Institute of Neurological Disorders and Stroke. The grant, entitled "A2a Adenosine Agonists as...

$42.8M raised in private placement financing.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- Agensys, Inc. completed a private placement financing for gross proceeds of $42.8 million. JPMorgan H&Q acted as the exclusive placement agent and financial advisor for the offering. Bear Stearns...

Company reports second quarter, first-half results.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- Alexion Pharmaceuticals, Inc., (ALXN) announced financial results for its second fiscal quarter and half year ended January 31, 2002. In its second quarter ended January 31, 2002, Alexion received...

Company announces financial expectations for 2002, results for 2001.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- Alpharma, Inc., (ALO), a leading global specialty pharmaceutical company, announced financial guidance for the year 2002. The company estimates that full year revenue in 2002 will approximate $1.2...

OvaRex pharmacokinetics study.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- AltaRex Corp., (AXO.TO) a developer of foreign antibodies that activate the immune system to treat cancer, announced that it has commenced, as scheduled, its OvaRex human pharmacokinetic study with the...

Private placement of special warrants could raise up to $7 million.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- AltaRex Corp., (AXO.TO) announced that it has issued 185.7 Special Warrants as part of an offering of up to 1000 Special Warrants on a private placement basis. If fully subscribed, the offering...

Company announces year-end, 4Q results.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- Alteon, Inc., (ALT) announced total revenues of $452,000 and a net loss of $11,583,000 for the 12 months ended December 31, 2001. This compares with total revenues of $570,000 and a net loss of...

American Home Products announces election of Wold as VP, taxes.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- American Home Products Corp. (AHP) announced the election of Mary Katherine Wold to the position of vice president, taxes, American Home Products Corporation. Wold succeeds Thomas Nee, who after 15...

Phase I trials commence for AGI-1096 for prevention of organ transplant rejection.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- AtheroGenics, Inc., (AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, has begun a phase I clinical trial of AGI-1096 as an oral treatment for the prevention of...

Eligard licensed for marketing in Israel.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc., (ATRX) has signed an exclusive licensing agreement with Luxembourg Pharmaceuticals, Ltd., for the Israeli marketing rights for its four Eligard, leuprolide acetate, prostate...

Nationwide program to foster collaboration, enhance local-level quality of healthcare.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- More than 600 healthcare leaders and advocates nationwide will participate in a newly launched, multidimensional, city-to-city program designed to help prompt greater collaboration in the delivery of...

Australian biotech company poised to change quantitative DNA analysis.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- BTF Decisive Microbiology (BTF) announced the application of its bioparticle dispensing technology platform to providing precision in quantitative DNA analysis. Mark Gauci, chief executive officer...

Companies ink agreement to develop generic conjugated estrogens.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc., (BRL) announced that it has signed a series of agreements with Natural Biologics, LLC to develop an "AB" rated conjugated estrogens product based on Natural Biologics'...

NDA submitted for once-daily ciprofloxacin HCl, ciprofloxacin.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- Bayer Corp., Pharmaceutical Division, has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) to market Cipro (ciprofloxacin hydrochloride and ciprofloxacin) in a...

Launching blockbusters: Early investments fuel maximum impact.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- In the race to boost market uptake to a maximum first-year peak, pharmaceutical executives ramp up investments in prelaunch marketing activities, according to a report from pharmaceutical research firm...

Stock symbol changed.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- Bio-Rad Laboratories, Inc., (BIO.A, BIO.B, BIO, BIO.B) has changed the symbol for its Class A shares on the American Stock Exchange from BIO.A to BIO. This change was to take effect at the opening...

OGS enters therapeutic antibodies alliance.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- Oxford GlycoSciences, Plc, (OGSI) and BioInvent International AB (BINV) announced a 3-year collaboration to identify, develop, manufacture, and commercialize therapeutic antibodies, which will target...

Covalent Group to conduct clinical trial of hemostatic agent for use in cardiothoracic surgery.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- Covalent Group, Inc., (CVGR) announced the signing of a $2.7 million contract with a major U.S. based biopharmaceutical company, which is sponsoring a phase 3 clinical program in subjects undergoing...

aaiPharma signs agreement to acquire Darvon and Darvocet N family.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- aaiPharma, Inc., (AAII) has announced that its NeoSan Pharmaceuticals business unit has entered into an agreement to purchase the United States rights to the Darvon (propoxyphene hydrochloride) and...

Clinical study results for Electroporation therapy to be announced at major cancer conference.
April 10, 2002... 2002 APR 10 - (NewsRx.com & NewsRx.net) -- Genetronics Biomedical Corp., San Diego, (GEB) announced that an abstract submitted recently was accepted for the 2002 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando,...